Anti-infection Agents
|
|
- Angel Allison
- 5 years ago
- Views:
Transcription
1
2 Pisutam (Lyo) Lyo for Inj. 2.25g 1 Pisutam (Lyo) Lyo for Inj. 4.5g 1 Pisutam Pow. for Inj. 2.25g 1 Pisutam Pow. for Inj. 4.5g 2 Picillina Pow. for Inj. 2g 2 Picillina Pow. for Inj. 4g 2 Ocillina Pow. for Inj. 0.5g 3 Ocillina Pow. for Inj. 1g 3 PenicillinV Tab U 3 Ansullina Pow. for Inj. 1.5g 4 Anbicyn Pow. for Inj. 0.6g 4 Anbicyn Pow. for Inj. 1.2g 4 Anbicyn F.C. Tablets 375mg 5 Anbicyn F.C.Tablets 625mg 5 Amoxicillin Cap. 500mg 5 Supecef Pow. for Inj. 0.5g 6 Supecef Pow. for Inj. 1g 6 Cefuroxime Pow. for Inj. 750mg 6 Tatumcef Pow. for Inj 0.5g 7 Tatumcef Pow. for Inj 1g 7 Tatumcef Pow. For Inj. 2g 7 Colirocin FCT. 250mg 8 Teicod Lyophilized 200 mg 9 Lyo-Vancin Lyophilized 500 mg 9 Myron Pow. for Inj. 0.25g 10 Myron Pow. for Inj. 0.5g 10
3 Culin Pow. for Inj. 0.25g 10 Culin Pow. for Inj. 0.5g 11 Leflodal F. C. Tab. 500 mg 12 Leflodal F. C. Tab. 100mg 12 Leflodal I.V. Solution 500mg/V 12 Ciflodal F.C. Tablets 500 mg 13 Oflodal F.C. Tablets 100mg 13 Azol-flucon I.V. Injection 2 mg/ml 14 Azol-flucon CAP. 50mg 14 Lisim Tab. 250mg 14 Acylete Tab. 400mg 15 Acylete Tab. 200mg 15 Sulbactam Pow. for Inj. 500mg 16 Clindamycin Cap. 150mg 16 Clindamycin Inj. 300mg 16 Hand Sanitizer Gel 60ml 17 Hand Sanitizer Gel 500ml 17 Hand Sanitizer Gel 3.8L 17 Anti-A Solution Solution 500ml 18 Hand Sanitizer Solution 500ml 18
4 Penicillins Pisutam (Lyo) R57 Lyo for Inj. 2.25g Pisutam (Lyo) R59 Lyo for Inj. 4.5g Pisutam K44 Pow. for Inj. 2.25g PIP-TZ PIP-TZ PIP-TZ Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. 2.25GM*10V AC510362CX 4.5GM*10V AC GM*10V AC466872CX
5 Penicillins Pisutam Picillina Picillina K51 K36 K37 Pow. for Inj. Pow. for Inj. Pow. for Inj. 4.5g 2g 4g PIP-TZ Piperacillin Piperacillin Moderate to severe infections caused B-lactamase producing bacterial strains that are susceptible to Piperacillin, have resistance to Piperacillin, but are susceptible to Piperacillin/Tazobactam. Systemic and local infections caused by gram negative and positive anaerobic bacteria and obligate aerobic bacteria. Systemic and local infections caused by gram negative and positive anaerobic bacteria and obligate aerobic bacteria. 4.5GM*10V AC GM*10V AC GM*10V AC
6 Penicillins Ocillina Ocillina PenicillinV K54 K53 D16 Pow. for Inj. Pow. for Inj. Tab. 0.5g 1g U Oxacillin Oxacillin Penicillin Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. All symptoms caused by microbes susceptible to Penicillin.(Please IPC) 0.5GM*25V AC GM*10V AC C/PTP/1000C/BTL NC024791G0
7 Penicillins Ansullina K38 Pow. for Inj. 1.5g Anbicyn P31 Pow. for Inj. 0.6g Anbicyn P30 Pow. for Inj. 1.2g Ampicillin/Subactam Amox/Clav Amox/Clav Infectious diseases induced by Streptococcus, Staphylococcus, E.coli, Klebsiela..(Please see IPC) Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. 1.5GM*10V AC MG*10V AC GM*10V AC
8 Penicillins Anbicyn Anbicyn Amoxicillin E111 E103 B32 F.C. Tablets F.C.Tablets Cap. 375mg 625mg 500mg Amox/Clav Amox/Clav Amoxicillin Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcuspneumonia, Meningococcus, and other susceptible bacteria. 100T/PTP AC T/PTP AC C/BTL AC /AC241321G0
9 Cephalosporins Supecef Supecef Cefuroxime K55 K58 K25 Pow. for Inj. Pow. for Inj. Pow. for Inj. 0.5g 1g 750mg Cefepime Cefepime Cefuroxime Infectious diseases caused by bacteria susceptible to Cefepime. Infectious diseases caused by bacteria susceptible to Cefepime. Infectious diseases 0.5GM*10V A GM*10V A MG*25V A
10 Cephalosporins Tatumcef Tatumcef Tatumcef K28 K31 K32 Pow. for Inj Pow. for Inj Pow. For Inj. 0.5g 1g 2g Ceftazidime Ceftazidime Ceftazidime It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). 0.5GM*10V A GM*5V A GM*1V A
11 Macrolides Colirocin E116 FCT. 250mg Clarithromycin Infectious diseases of the upper and lower airway caused by infectious bacteria. Can be used in conjunction with Omeprazole to treat duodenal ulcer associated with H. pylori. (Please see IPC) 28T/PTP;500T/BTL AC
12 Glycopeptide Teicod Lyo-Vancin R53 R52 Lyophilized Lyophilized 200 mg 500 mg Teicoplanin vancomycin Endocarditis, osteomyelitis, pneumonia, septicemia, soft tissue infections, and enteritis caused by Staphylococcus infection; pseudomembranous colitis caused by Clostridium infection. Endocarditis, osteomyelitis, pneumonia, septicemia, soft tissue infections, and enteritis caused by Staphylococcus infection; pseudomembranous colitis caused by Clostridium infection. 3ML*VIAL AC MG*10V AC
13 Carbapenems Myron K46 Pow. for Inj. 0.25g Myron K48 Pow. for Inj. 0.5g Culin K56 Pow. for Inj. 0.25g Meropenem Meropenem Imipenem/Cilastatin Infectious diseases induced by Meropenem-susceptible bacteria. Infectious diseases induced by Meropenem-susceptible bacteria. Infectious diseases induced by Imipenem-susceptible gram negative and positive bacteria. 0.25GM*10V AC GM*10V AC GM*25V AC
14 Carbapenems Culin K57 Pow. for Inj. 0.5g Imipenem/Cilastatin Infectious diseases induced by Imipenem-susceptible gram negative and positive bacteria. 0.5GM*25V AC
15 Quinolones Leflodal Leflodal Leflodal E147 E146 P43 F. C. Tab. F. C. Tab. I.V. Solution 500 mg 100mg 500mg/V Levofloxacin Levofloxacin Levofloxacin Treatment infections in adults caused by Levofloxacin-susceptible pathogens. Please see IPC for more information. Airway infectious diseases, otorhinolaryngological diseases, UTI, uterine infections, etc. Please see IPC for more information. Treatment of the following infections in adults caused by Levofloxacinsusceptible pathogenic bacteria: CAP, UTI, SSSI, etc. Please see IPC for more information. 100T/PTP AC T/PTP AC mg/ml*100ml AC
16 Quinolones Ciflodal Oflodal E81 E89 F.C. Tablets F.C. Tablets 500 mg 100mg Ciprofloxacin Ofloxacin Infections disease. (Please see IPC) Infectious diseases (Please see IPC) 80T/PTP;100T/BTL AC T/BTL AC
17 Antifungal Agents Azol-flucon Azol-flucon Lisim P42 B51 D63 I.V. Injection CAP. Tab. 2 mg/ml 50mg 250mg Fluconazole Fluconazole Terbinafine Antifungal agent. Local or systemic Candida infection, Cryptococcic infection, prevention of fungal infections in AIDS patients. Onychomyosis, tineacapitis, and severe, wide spread dermatomycosis not responding to local treatment. 10 VIAL AC C/PTP ; 3*12C/PTP AC T/PTP;140T/PTP AC
18 Antiviral Agents Acylete Acylete D54 D57 Tab. Tab. 400mg 200mg Acyclovir Acyclovir Infections induced by herpes zoster virus, skin and mucous membrane infections induced by herpes simplex virus. (Please see IPC) Infections induced by herpes zoster virus, skin and mucous membrane infections induced by herpes simplex virus.(please see IPC) 100T/BTL AC T/BTL 100T/PTP AC
19 Others Sulbactam Clindamycin Clindamycin K59 B38 M52 Pow. for Inj. Cap. Inj. 500mg 150mg 300mg Sulbactam Clindamycin Clindamycin A β-lactamase inhibitor, that have to combinate with Ampicillin. Treatment of Staphylococcus, Streptococcus, Streptococcus pneumonia, and other infectious bacteria susceptible to this drug. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, anaerobic bacteria, and other susceptible bacteria. 500MG*10V A C/BTL AC ML*50A AC
20 Others Hand Sanitizer Hand Sanitizer Hand Sanitizer F42 F42 F42 Gel Gel Gel 60ml 500ml 3.8L Ethylalcohol Ethylalcohol Ethylalcohol Skin and hand cleaning, disinfection, germicidal. Skin and hand cleaning, disinfection, germicidal. Skin and hand cleaning, disinfection, germicidal. 60ML/BTL 500ML/BTL 3.8L/BTL 17
21 Others Anti-A Solution Hand Sanitizer F06 F45 Solution Solution 500ml 500ml Benzalkonium Cl. Ethylalcohol Germicidal, disinfection. Skin and hand cleaning, disinfection, germicidal. 500ml 500ML/BTL 18
22
Anti-infection Agents
Supecef Pow. for Inj. 0.5g 1 Supecef Pow. for Inj. 1g 1 Cefuroxime Pow. for Inj. 750mg 1 Tatumcef Pow. for Inj 0.5g 2 Tatumcef Pow. for Inj 1g 2 Tatumcef Pow. For Inj. 2g 2 Cefazolin Injection 1g 3 Pisutam
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationMedicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!
Medicinal Chemistry 561P 2 st hour Examination May 6, 2013 NAME: KEY Good Luck! 2 MDCH 561P Exam 2 May 6, 2013 Name: KEY Grade: Fill in your scantron with the best choice for the questions below: 1. Which
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems
β-lactams ß-lactams Sub-families Penicillins Cephalosporins Monobactams Carbapenems ß-lactams Mode of action PBPs = Trans/Carboxy/Endo- peptidases PBP binding (Penicillin-Binding Proteins) activation of
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationChapter 46. Learning Objectives (cont d)
Chapter 46 Antimicrobial Agents Learning Objectives Explain the major action and effects of drugs used to treat infectious diseases Identify criteria used to select an effective antimicrobial agent Identify
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More information3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC
rd 3 party manufacturing PRODUCT LIST Category : ANTI BIOTIC ANTI BIOTIC SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 1 Amikacin Sulphate IP 500mg/2ml DRUG LIQUID INJ. VIAL 2 Amoxicillin 200mg & Clavulanic
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationAntibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi
Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationCell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification
Cell Wall Weakeners Antimicrobials: Drugs that Weaken the Cell Wall Beta Lactams Penicillins Cephalosporins Carbapenems Aztreonam Vancomycin Teicoplanin Bacterial Cell Wall Bacterial cytoplasm is hypertonic
More informationInterpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes
Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi
More informationnumber Done by Corrected by Doctor
number 28 Done by Dina Yaseen Corrected by حسام أبو عوض Doctor مالك الزحلف Cephalosporins -Cephalosporins are β-lactam antibiotics isolated from a strain of Streptomyces. -They are bactericidal and work
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More information** the doctor start the lecture with revising some information from the last one:
Page 1 of 7 ** the doctor start the lecture with revising some information from the last one: #penicillin G has a good susceptibility against gram(+ve), Neisseria (-ve) #mostly active against strep. (don
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationInhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationAntibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
More informationAntibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut
Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationPenicillins - EUCAST clinical MIC breakpoints (version 1.3)
EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationAntimicrobial Stewardship Program
Antimicrobial Stewardship Program David R. Woodard, MSc, FSHEA, CIC CDC: Antibiotic Resistance Threats in the United States, 2013 http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ CDC Threat Levels
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix O 3 December 2014 Final version Commissioned
More informationnumber Done by Corrected by Doctor
number 32 Done by Nazek Hyasat Corrected by Doctor مالك الزحلف In this sheet we will talk about two cute drugs and a group of drugs, wish you a pleasant study... First of all, we will talk about clindamycin,which
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationRational use of antibiotics
Rational use of antibiotics Uga Dumpis MD, PhD,, DTM Stradins University Hospital Riga, Latvia ugadumpis@stradini.lv BALTICCARE CONFERENCE, PSKOV, 16-18.03, 18.03, 2006 Why to use antibiotics? Prophylaxis
More informationAntibiotics 1. Lecture 8
Antibiotics 1 Lecture 8 Overview of antibiotics What am I treating? Viral, bacterial, fungal, mycobacterial, etc. Who am I treating? Host factors: age, genetic factors, co-morbidities (renal and liver
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationAminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.
Aminoglycosides The only bactericidal protein synthesis inhibitors. They bind to the ribosomal 30S subunit. Inhibit initiation of peptide synthesis and cause misreading of the genetic code. Streptomycin
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationInfectious Disease: Drug Resistance Pattern in New Mexico
Infectious Disease: Drug Resistance Pattern in New Mexico Are these the world's sexiest accents? Obi C. Okoli, MD.,MPH. Clinic for Infectious Diseases Las Cruces, NM. Are these the world's sexiest accents?
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationAntimicrobial Therapy
Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Disclosure: Dr. Spach has no significant financial interest in any of the
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More information5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)
Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationnumber Done by Corrected by Doctor Dr.Malik
number 27 Done by Fatimah Farhan Corrected by Basil Al-Bakri Doctor Dr.Malik Note: anything in red is just extra info and you will not be asked about it in the exam. In this sheet we will continue talking
More informationSuggested treatment. Inj Crystalline Penicillin 50,000U/Kg i.v. 4-6hrly (if child cannot swallow) 40mg/Kg/dose BID x 10days
GUIDELINES FOR TREATMENT OF INFECTIONS IN CHILDREN A. RESPIRATORY TRACT INFECTIONS UPPER RESPIRATORY TRACT INFECTIONS Infection/Condition/likely organism Suggested treatment Preferred Alternative Acute
More informationRate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules
KAPL list of products applicable for Institutional/Hospital supplies under Pharmaceuticals Purchase Policy (PPP) issued by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India
More informationMonthly Webinar. Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm. Event number: Audio dial-in (phone):
Monthly Webinar Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm Event number: 849 291 546 Audio dial-in (phone): 01 526 0058 AMS InSight Monthly Webinar: Tuesday 12th December MicroB: Brewing
More informationDR. BASHIRU BOI KIKIMOTO
OVERVIEW OF ANTIMICROBIAL RESISTANCE AND ANTIMICROBIAL USE IN GHANA PRESENTED BY : DR. BASHIRU BOI KIKIMOTO DVM. PhD VETERINARY PUBLIC HEALTH HEAD - PUBLIC HEALTH UNIT & FOOD SAFETY UNIT VENUE: SWATZILAND
More informationStudies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India
Human Journals Research Article April 2016 Vol.:6, Issue:1 All rights are reserved by Zarine Khety et al. Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Keywords: Drug
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More information